Most Read Articles
06 Dec 2018
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.

Self-reported erectile dysfunction tied to increased CVD risk

Rachel Soon
Medical Writer
02 Aug 2018

Older men who report erectile dysfunction (ED) may be at greater risk of cardiovascular disease (CVD) independent of other risk factors such as LDL cholesterol, smoking and high blood pressure.

In a recent analysis based on data from the ongoing MESA* prospective cohort study, researchers found that men between ages 60 to 78 who self-reported ED were up to two times as likely to experience heart attacks, cardiac arrests, sudden cardiac death and fatal or non-fatal strokes over a 4-year period. [Circulation 2018; doi:10.1161/CIRCULATIONAHA.118.0339]

"Our results reveal that erectile dysfunction is, in and of itself, a potent predictor of cardiovascular risk," says study senior investigator Dr Michael Blaha, associate professor of medicine at the Johns Hopkins School of Medicine in Baltimore, Maryland, USA. "Our findings suggest that clinicians should perform further targeted screening in men with erectile dysfunction regardless of other cardiac risk factors and should consider managing [the risk factors] that much more aggressively."

For an average of 3.8 years, Blaha’s team followed a subset of 1,757 male participants in the MESA study who were of mean age 69±9.2 years, had submitted an answer to the Massachusetts Male Aging Study (MMAS), and were free of CVD events at baseline. The cohort was an ethnically mixed group consisting of 42.3% white, 24.2 percent African American, 10.5 percent Chinese American, and 22.9 percent Hispanic individuals. ED symptoms were reported by 877 (45.8 percent) participants.

Of the participants, 877 had self-reported ED (based on a reply of “never able” or “sometimes able” to the MMAS assessment).

Blaha’s team aimed to investigate the value of self-reported ED as a predictor of incident coronary heart disease (CHD) and CVD. Outcomes of hard CVD events were assessed, which included all hard CHD events (myocardial infarction, resuscitated cardiac arrest, and CHD death), plus stroke and stroke death.

During the 4-year follow-up, a total of 75 hard CVD events were observed among the cohort, with a significantly greater proportion of participants with self-reported ED experiencing them than those without ED (6.3% versus 2.6%, p<0.001).

Analysis through Cox proportional hazard models showed that ED was a significant predictor of hard CVD events (hazard ratio, 1.9; 95% confidence interval, 1.1–3.4), even when the data was adjusted for smoking status, diabetes mellitus, family history of CHD, total/high-density lipoprotein cholesterol ratio, systolic blood pressure, antihypertensive medication use, lipid-lowering medication use, β-blocker use and depression.

ED, defined as the inability to achieve or maintain an erection for satisfactory sexual intercourse, affects nearly 20 percent of men over 20 years of age. CVD and ED share common risk factors including obesity, hypertension, smoking, diabetes and metabolic syndrome.

While limited evidence of a link between ED and CVD has emerged in recent years, the results of this latest study may provide the strongest indication to date that sexual dysfunction indicates heightened cardiovascular risk, the researchers said.

“Our study had certain limitations. Although similar to the primary care assessment of ED, the single Massachusetts Male Aging Study question does not distinguish between vascular and nonvascular types of ED, which may have attenuated the association between ED and CVD,” wrote the researchers. “In addition, because our follow-up was just 3.8 years, additional 10-year data on the risk predictive value of ED are needed.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
06 Dec 2018
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.